Literature DB >> 14637156

Deficit of CD38/cyclic ADP-ribose is differentially compensated in hearts by gender.

Jun Takahashi1, Yutaka Kagaya, Ichiro Kato, Jun Ohta, Shogen Isoyama, Masahito Miura, Yoshinao Sugai, Masanori Hirose, Yuji Wakayama, Mototsugu Ninomiya, Jun Watanabe, Shin Takasawa, Hiroshi Okamoto, Kunio Shirato.   

Abstract

To elucidate whether myocardial CD38/cyclic ADP-ribose (cADPR) signaling plays a physiological role, we investigated the heart of CD38 knockout mice (CD38KO). In CD38KO, the myocardial cADPR content was reduced by 85% compared with wild-type mice (WT). Cardiac hypertrophy developed only in males. At 36 degrees C, none of the parameters for Ca(2+) transients and forces of the papillary muscles differed between WT and CD38KO. In contrast, at 27 degrees C, at which cADPR does not work, the peak [Ca(2+)](i) was increased and the decline in [Ca(2+)](i) was accelerated in CD38KO compared with WT. In CD38KO, the protein expression of SR Ca(2+) ATPase type2 (SERCA2) and the SERCA2-to-phospholamban ratio were increased compared with WT. The ryanodine receptor protein was increased only in female CD38KO compared with WT. These data suggest that the CD38/cADPR signaling plays an important role in intracellular Ca(2+) homeostasis in cardiac myocytes in vivo. Its deficiency was compensated differentially according to gender.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14637156     DOI: 10.1016/j.bbrc.2003.10.143

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Structure and enzymatic functions of human CD38.

Authors:  Hon Cheung Lee
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

Review 2.  Roles and mechanisms of the CD38/cyclic adenosine diphosphate ribose/Ca(2+) signaling pathway.

Authors:  Wenjie Wei; Richard Graeff; Jianbo Yue
Journal:  World J Biol Chem       Date:  2014-02-26

3.  A multiscale analysis in CD38-/- mice unveils major prefrontal cortex dysfunctions.

Authors:  Lora L Martucci; Muriel Amar; Remi Chaussenot; Gabriel Benet; Oscar Bauer; Antoine de Zélicourt; Anne Nosjean; Jean-Marie Launay; Jacques Callebert; Catherine Sebrié; Antony Galione; Jean-Marc Edeline; Sabine de la Porte; Philippe Fossier; Sylvie Granon; Cyrille Vaillend; José-Manuel Cancela
Journal:  FASEB J       Date:  2019-03-07       Impact factor: 5.191

Review 4.  The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.

Authors:  Julianna D Zeidler; Kelly A Hogan; Guillermo Agorrody; Thais R Peclat; Sonu Kashyap; Karina S Kanamori; Lilian Sales Gomez; Delaram Z Mazdeh; Gina M Warner; Katie L Thompson; Claudia C S Chini; Eduardo Nunes Chini
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-09       Impact factor: 4.249

5.  Mice lacking the ADP ribosyl cyclase CD38 exhibit attenuated renal vasoconstriction to angiotensin II, endothelin-1, and norepinephrine.

Authors:  Tiffany L Thai; William J Arendshorst
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-29

Review 6.  CD38: A Potential Therapeutic Target in Cardiovascular Disease.

Authors:  Wanyun Zuo; Na Liu; Yunhong Zeng; Yaozhong Liu; Biao Li; Keke Wu; Yunbin Xiao; Qiming Liu
Journal:  Cardiovasc Drugs Ther       Date:  2021-08       Impact factor: 3.727

7.  Benefits in cardiac function by CD38 suppression: Improvement in NAD+ levels, exercise capacity, heart rate variability and protection against catecholamine-induced ventricular arrhythmias.

Authors:  Guillermo Agorrody; Thais R Peclat; Gonzalo Peluso; Luis A Gonano; Leonardo Santos; Wim van Schooten; Claudia C S Chini; Carlos Escande; Eduardo N Chini; Paola Contreras
Journal:  J Mol Cell Cardiol       Date:  2022-02-01       Impact factor: 5.763

8.  Inhibition of cardiomyocytes differentiation of mouse embryonic stem cells by CD38/cADPR/Ca2+ signaling pathway.

Authors:  Wen-Jie Wei; Hai-Ying Sun; Kai Yiu Ting; Li-He Zhang; Hon-Cheung Lee; Gui-Rong Li; Jianbo Yue
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

9.  CD38 Deficiency Protects the Heart from Ischemia/Reperfusion Injury through Activating SIRT1/FOXOs-Mediated Antioxidative Stress Pathway.

Authors:  Xiao-Hui Guan; Xiao-Hong Liu; Xuan Hong; Ning Zhao; Yun-Fei Xiao; Ling-Fang Wang; Ling Tang; Kai Jiang; Yi-Song Qian; Ke-Yu Deng; Guangju Ji; Mingui Fu; Hong-Bo Xin
Journal:  Oxid Med Cell Longev       Date:  2016-07-31       Impact factor: 6.543

10.  Specific cyclic ADP-ribose phosphohydrolase obtained by mutagenic engineering of Mn2+-dependent ADP-ribose/CDP-alcohol diphosphatase.

Authors:  João Meireles Ribeiro; José Canales; Alicia Cabezas; Joaquim Rui Rodrigues; Rosa María Pinto; Iralis López-Villamizar; María Jesús Costas; José Carlos Cameselle
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.